(CME) CME - NASDAQ
Sector: Financial Services | Industry: Financial Data & Stock Exchanges | Exchange: NASDAQ (USA) | Market Cap: 88.596m USD | Total Return: -15.9% in 12m
Avg Turnover: 1.06B
EPS Trend: 99.4%
Qual. Beats: 0
Rev. Trend: 98.8%
Qual. Beats: -1
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
CME Group Inc. is a global operator of regulated derivatives exchanges, offering futures and options contracts across interest rates, equity indexes, foreign exchange, and agricultural, energy, and metals commodities. Beyond trading, the company runs clearing house services that guarantee and settle these contracts, and provides real-time and historical market data products. Its customer base spans professional traders, financial institutions, corporations, governments, and central banks.
Headquartered in Chicago and founded in 1898, the company was reorganized under the CME Group name in 2007, consolidating what had been the Chicago Mercantile Exchange. As a large-cap Financials stock in the Financial Exchanges & Data sub-industry, CME monetizes activity through a mix of transaction fees, clearing fees, and data subscriptions, with its central counterparty role functioning much like a utility for the global derivatives market.
- Fed rate volatility drives interest rate futures trading volume
- Market data services deliver high-margin recurring revenue growth
- Capital allocation through dividends and buybacks supports shareholder returns
| Net Income: 4.24b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.28 > 1.0 |
| NWC/Revenue: 44.44% < 20% (prev 32.23%; Δ 12.21% < -1%) |
| CFO/TA 0.02 > 3% & CFO 4.42b > Net Income 4.24b |
| Net Debt (907.8m) to EBITDA (5.99b): 0.15 < 3 |
| Current Ratio: 1.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (363.2m) vs 12m ago 0.83% < -2% |
| Gross Margin: 86.34% > 18% (prev 86.46%; Δ -0.12% > 0.5%) |
| Asset Turnover: 3.76% > 50% (prev 3.98%; Δ -0.23% > 0%) |
| Interest Coverage Ratio: 32.59 > 6 (EBIT TTM 5.71b / Interest Expense TTM 175.3m) |
| A: 0.01 (Total Current Assets 169b - Total Current Liabilities 166b) / Total Assets 202b |
| B: 0.02 (Retained Earnings 4.88b / Total Assets 202b) |
| C: 0.03 (EBIT TTM 5.71b / Avg Total Assets 180b) |
| D: 0.15 (Book Value of Equity 26.6b / Total Liabilities 175b) |
| Altman-Z'' = 0.55 = B |
| DSRI: 1.13 (Receivables 935.5m/770.2m, Revenue 6.76b/6.28b) |
| GMI: 1.00 (GM 86.46% / 86.34%) |
| AQI: 0.75 (AQ_t 0.16 / AQ_t-1 0.22) |
| SGI: 1.08 (Revenue 6.76b / 6.28b) |
| TATA: -0.00 (NI 4.24b - CFO 4.42b) / TA 202b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of June 28, 2026, the stock is trading at USD 221.00 with a total of 5,945,921 shares traded. Over the past week, the price has changed by -10.30%, over one month by -21.38%, over three months by -25.35% and over the past year by -15.85%.
Current recommended Stop Loss: 208.40 (which is 5.7% or 1.5 ATR below the current price).
CME has received a consensus analysts rating of 3.31. Therefore, it is recommended to hold CME.
- StrongBuy: 3
- Buy: 3
- Hold: 7
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 305.9 | 38.4% |
P/E Trailing = 20.9215
P/E Forward = 20.1207
P/S = 13.1378
P/B = 3.3444
P/EG = 4.3195
Revenue TTM = 6.76b USD
EBIT TTM = 5.71b USD
EBITDA TTM = 5.99b USD
Long Term Debt = 3.42b USD (from longTermDebt, last quarter)
Short Term Debt = 55.8m USD (from shortTermDebt, last fiscal year)
Debt = 3.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 907.8m USD (calculated: Debt 3.42b - CCE 2.52b)
Enterprise Value = 89.5b USD (88.6b + Debt 3.42b - CCE 2.52b)
Interest Coverage Ratio = 32.59 (Ebit TTM 5.71b / Interest Expense TTM 175.3m)
EV/FCF = 20.67x (Enterprise Value 89.5b / FCF TTM 4.33b)
FCF Yield = 4.84% (FCF TTM 4.33b / Enterprise Value 89.5b)
FCF Margin = 64.06% (FCF TTM 4.33b / Revenue TTM 6.76b)
Net Margin = 62.77% (Net Income TTM 4.24b / Revenue TTM 6.76b)
Gross Margin = 86.34% ((Revenue TTM 6.76b - Cost of Revenue TTM 923.3m) / Revenue TTM)
Gross Margin QoQ = 88.14% (prev 85.38%)
Tobins Q-Ratio = 0.44 (Enterprise Value 89.5b / Total Assets 202b)
Interest Expense / Debt = 5.12% (Interest Expense 175.3m / Debt 3.42b)
Taxrate = 23.96% (1.34b / 5.60b)
NOPAT = 4.34b (EBIT 5.71b * (1 - 23.96%))
Current Ratio = 1.02 (Total Current Assets 169b / Total Current Liabilities 166b)
Debt / Equity = 0.13 (Debt 3.42b / totalStockholderEquity, last quarter 26.6b)
Debt / EBITDA = 0.15 (Net Debt 907.8m / EBITDA 5.99b)
Debt / FCF = 0.21 (Net Debt 907.8m / FCF TTM 4.33b)
Total Stockholder Equity = 27.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.36% (Net Income 4.24b / Total Assets 202b)
RoE = 15.25% (Net Income TTM 4.24b / Total Stockholder Equity 27.8b)
RoCE = 18.29% (EBIT 5.71b / Capital Employed (Equity 27.8b + L.T.Debt 3.42b))
RoIC = 12.16% (NOPAT 4.34b / Invested Capital 35.7b)
WACC = 5.15% (E(88.6b)/V(92.0b) * Re(5.20%) + D(3.42b)/V(92.0b) * Rd(5.12%) * (1-Tc(0.24)))
Discount Rate = 5.20% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.11 | Cagr: 0.43%
[DCF] Terminal Value 77.68% ; FCFF base≈4.13b ; Y1≈4.66b ; Y5≈6.58b
[DCF] Fair Price = 272.7 (EV 99.4b - Net Debt 907.8m = Equity 98.5b / Shares 361.3m; r=8.35% [WACC [floored]]; 5y FCF grow 13.15% → 2.50% )
EPS Correlation: 99.37 | EPS CAGR: 11.32% | SUE: -0.41 | # QB: 0
Revenue Correlation: 98.78 | Revenue CAGR: 9.49% | SUE: -2.11 | # QB: -1
EPS current Quarter (2026-06-30): EPS=2.98 | Chg30d=+0.13% | Revisions=+0% | Analysts=13
EPS next Quarter (2026-09-30): EPS=2.97 | Chg30d=+0.04% | Revisions=+33% | Analysts=13
EPS current Year (2026-12-31): EPS=12.28 | Chg30d=+0.16% | Revisions=+43% | GrowthEPS=+9.6% | GrowthRev=+8.0%
EPS next Year (2027-12-31): EPS=12.92 | Chg30d=+0.33% | Revisions=+43% | GrowthEPS=+5.2% | GrowthRev=+4.3%
[Analyst] Revisions Ratio: +43%